Amidst the promising headlines of the rapidly advancing cell and gene therapy industry, one key challenge has risen to the top in recent news. The article “A CAR-T bottleneck: Centers that collect patient cells feel crunch from growing demand” published by STAT, discusses essential next steps to relieving the burden on essential industry infrastructure.
Stakeholders are beginning to rally around solutions, including an effort to standardize protocols and centralize audits of apheresis centers. Be The Match BioTherapies®, which recently hosted a Standardization Summit with industry-leading therapy developers, apheresis professionals and standards accrediting bodies, has assumed the lead in ensuring that efforts move forward.
According to Amy Hines, our Director of Collection Network Management, “Our organization is well-positioned to take on a leadership role in solving these challenges. Centers that have relied on us for 30 years can continue to rely on us for these therapies as well.”
Learn more about our established relationships and standardized training processes for apheresis and collection facilities.
Onboard cell collection facilities faster by obtaining our audit results measuring compliance with Good Tissue Practice (GTP), Good Manufacturing Practice (GMP)
and other applicable quality measures.